StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > We are getting closer the the mother of all resistance!!!

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Jan 14, 2021 10:20am

133 Views

Post# 32293476

RE:RE:RE:RE:RE:We are getting closer the the mother of all resistance!!!

They are saying it should have been $4 after the Q3 results in November/December.

That's aggressive but I thought we should have been at least at a new 52 week high at say $1.50.

Q4 and year end end is due of March. Aristotle will be released sometime between today and end of March (Q1). Either of those alone would take us to new highs. Combined I can see $2.50-3.00 easily.

10 weeks left. Let's Go!!!